<DOC>
	<DOCNO>NCT02666703</DOCNO>
	<brief_summary>The modern era cardiac surgery begin early 1950s introduction cardiopulmonary bypass ( CPB ) . Although clearly show CPB almost unavoidable open heart operation , undesirable systemic inflammatory response syndrome ( SIRS ) associate use . This complex chain event strong similarity sepsis may contribute development postoperative complication multiple organ failure ( MOF ) . It show excessive compensatory anti-inflammatory response ( CARS ) SIRS lead immune paralysis increase rate hospital acquire infection . The balance pro-inflammatory anti-inflammatory mediator determine inflammatory response clinical outcome . Accordingly , great effort focus therapeutic intervention aim reduce inflammatory reaction CPB , include pharmacologic strategy modification surgical technique mechanical device . Such therapy may provide improvement patient outcome open heart operation . Among pharmacologic strategy prophylaxis corticosteroid , use open heart surgery 30 year . Many study , experimental clinical , fail produce evidence favor steroid treatment . As far medical device concern , use extracorporeal cytokine filter CytoSorb look promising cardiac surgery . It recently approve European Medicines Agency active treatment fight cytokine storm . Serum paraoxonase 1 ( PON1 ) lipo-lactonase , associate HDL anti-inflammatory role protects atherosclerosis . Low level PON1 associate venous graft occlusion patient coronary artery bypass grafting . PON1 reduce monocyte chemotaxis adhesion endothelial cell , lead inhibition differentiation monocytes macrophage . The effect cytokine adsorption therapy PON1 unknown . The aim study explore effect extracorporeal immunoadsorption CPB pro-inflammatory anti-inflammatory protective mediator cellular immune status cardiac surgery .</brief_summary>
	<brief_title>Extracorporeal Cytokine Adsorption Cardiac Surgery</brief_title>
	<detailed_description>Patients undergo complex cardiac surgery CPB ( eg : combine valve coronary bypass grafting surgery , concomitant valve surgery , surgery ascend aorta aortic arch , well re-operations type ) enrol study give sign informed consent . They randomize 3 group : 1. study ( CytoSorb ) group , 2. control group , 3. corticosteroid group . Immune response [ TNF-alfa ( tumor necrosis factor-alpha ) , IL ( interleukin ) -1 , IL-6 , IL-8 , IL-10 , complement C5a , lymphocyte cellular marker ( CD64 , CD163 ) , miRNA ( micro RNA ) , PON1 activity , well lipid status , hs-CRP ( high sensitivity C-reactive protein ) , PCT ( procalcitonin ) acute phase protein , determine CPB , CPB , immediately , 24h , 48h 5 day CPB . We document demographic characteristic patient , preoperative medical status , well intraoperative data ( type duration surgery , duration CPB , period ischemia , hemodynamic parameter , usage inotropic/vasoactive therapy , insulin , fluid , blood blood component ) ; duration mechanical ventilation intensive care unit ( ICU ) , duration ICU stay , 30-day mortality morbidity , well postoperative complication ( bleed , hemodynamic instability , impaired respiratory function , infection , worsen renal , liver cognitive function ) .</detailed_description>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Elective complex cardiac surgery ( combine valve coronary bypass grafting surgery , concomitant valve surgery , surgery ascend aorta aortic arch , well reoperations type ) Age &gt; 18 year Disagreement participate study Age &lt; 18 year Pregnancy Emergency procedure Heart transplantation Implantation LVAD ( leave ventricular assist device ) , RVAD ( right ventricular assist device ) TAH ( total artificial heart ) Treatment chemotherapy , immunosuppressive therapy Treatment antileukocyte drug TNFalfa blocker Immunocompromised patient ( AIDS ) , leucopenia ( &lt; 4,0x109 / L ) Clinical and/or laboratory sign infection ( CRP &gt; 2 mg/dl ) Serum creatinine &gt; 2 mg/dl Bilirubin &gt; 2 mg/dl History stroke Malnourished patient , BMI &lt; 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>cardiac surgery</keyword>
	<keyword>systemic inflammatory response</keyword>
	<keyword>immunoadsorption</keyword>
</DOC>